Stone Ridge Asset Management’s Charles River Laboratories CRL Stock Holding History

Stone Ridge Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,740	Closed	-$363K	–	973
2019 Q3	$363K	Hold	2,740	–	–	0.02%	798
2019 Q2	$389K	Hold	2,740	–	–	0.02%	823
2019 Q1	$398K	Sell	2,740 -3,000	-52%	-$394K	0.02%	800
2018 Q4	$650K	Hold	5,740	–	–	0.04%	651
2018 Q3	$772K	Sell	5,740 -1,400	-20%	-$173K	0.04%	612
2018 Q2	$802K	Hold	7,140	–	–	0.05%	539
2018 Q1	$762K	Hold	7,140	–	–	0.04%	523
2017 Q4	$781K	Buy	+7,140	New	+$777K	0.05%	523

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Stone Ridge Asset Management's CRL Position: Q4 2019 in Review

Stone Ridge Asset Management sold out of Charles River Laboratories (CRL) in Q4 2019, closing a stake of 2,740 shares — an estimated $363K sold.

Stone Ridge Asset Management first reported a position in CRL in Q4 2017 and held it in 8 quarters. The position peaked at $802K in Q2 2018. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

Stone Ridge Asset Management reported no remaining Charles River Laboratories position as of Q4 2019 after selling out during the quarter.
Stone Ridge Asset Management sold 2,740 Charles River Laboratories shares in Q4 2019, an estimated $363K.
Stone Ridge Asset Management first reported a position in Charles River Laboratories in Q4 2017 and held it in 8 quarters.
Stone Ridge Asset Management's Charles River Laboratories position peaked at $802K in Q2 2018.
413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on Stone Ridge Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.